Richard joined Pappas Capital in 2022 as a Venture Partner. He is currently senior advisor to the Chairman and CEO of IQVIA. In this role, Richard supports IQVIA in several areas including strategic M&A, customer management and governance, leadership development, and business development support. In addition, he is an advisor to the President of IQVIA's Research & Development Solutions (R&D Solutions) global business unit and other IQVIA leaders.

Previously, Richard was President of R&D Solutions at IQVIA. Supported by high-powered information and technology assets, the clinical experts in R&D Solutions leverage comprehensive evidence-driven trial design, accelerate site activation and patient recruitment, and optimize trial execution. Richard also serves as chair of the R&D Solutions Executive Committee. Prior to his role as President of IQVIA's R&D Solutions business unit, Richard was president of Novella Clinical, a specialty clinical research organization acquired by Quintiles in 2013, and the leader of QuintilesIMS’s Global Functional Resourcing business. Richard joined Novella in 2004 and served as president and CEO from 2008-2013. Under his leadership, Novella became a distinctively agile, results oriented CRO in the highly complex and fast-growing areas of specialty pharma and medical technology. Prior to Novella, Richard was senior vice president of global business development for one of the world’s largest CROs. His career in the pharmaceutical industry began at Zeneca Pharmaceuticals in 1989, where he was given increasing responsibilities as a medical and hospital sales representative, cardiovascular portfolio analyst and marketing manager.

Education:

University of North Carolina at Chapel Hill (BS in Economics)